Literature DB >> 14004953

The complement-dependent bacteriolytic activity of normal human serum. I. The effect of pH and ionic strength and the role of lysozyme.

A C WARDLAW.   

Abstract

The bacteriolytic activity of normal human serum on a rough strain of E. coli has been studied by a turbidimetric method. Bacteriolysis was found to be markedly dependent on ionic strength and pH, with optima at micro = 0.06 and pH 8.3-8.5, respectively. The method of cultivating the cells also influenced the rapidity of lysis. Lysis was temperature-dependent and was exhibited by all samples of human serum tested. Microscopically, organisms incubated with serum were observed to swell, loose their rod shape and eventually burst, leaving remnants of the cell membrane in suspension. Sphaeroplasts were obtained by brief exposure of cells to serum followed by dilution into 5 per cent sucrose. The bacteriolytic reaction was shown to require complement. No definite requirement for properdin or specific antibody in this system could be demonstrated by the absorption of serum with zymosan and with homologous cells respectively. The latter procedure was found to reduce bacteriolytic activity by removal of serum lysozyme. Absorption of serum with bentonite also led to loss of bacteriolytic activity which could be restored with lysozyme. The organism was not lysed by lysozyme alone, but lysis occurred with lysozyme + EDTA in tris buffer. The possibility of complement acting independently of antibody or properdin, in certain instances, is discussed in relation to bacterial cell wall structure. Data are presented supporting the hypothesis that the "substrate" of complement in cell membranes is a lipid or lipoprotein.

Entities:  

Keywords:  BLOOD; COMPLEMENT; HYDROGEN-ION CONCENTRATION/blood; LYSOZYME/pharmacology

Mesh:

Substances:

Year:  1962        PMID: 14004953      PMCID: PMC2137394          DOI: 10.1084/jem.115.6.1231

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

1.  Bacteriolysis of Enterobacteriaceae. I. Lysis by four lytic systems utilizing lysozyme.

Authors:  E C NOLLER; S E HARTSELL
Journal:  J Bacteriol       Date:  1961-03       Impact factor: 3.490

2.  Bacteriolysis of Enterobacteriaceae. II. Pre- and co-lytic treatments potentiating the action of lysozyme.

Authors:  E C NOLLER; S E HARTSELL
Journal:  J Bacteriol       Date:  1961-03       Impact factor: 3.490

3.  Lysis of gram-negative organisms and the role of versene.

Authors:  R REPASKE
Journal:  Biochim Biophys Acta       Date:  1958-11

4.  Endotoxic properties of gramnegative bacteria and their susceptibility to the lethal effect of normal serum.

Authors:  J G MICHAEL; M LANDY
Journal:  J Infect Dis       Date:  1961 Jan-Feb       Impact factor: 5.226

5.  Effect of polymyxin on the lysis of Neisseria catarrhalis by lysozyme.

Authors:  G H WARREN; J GRAY; J A YURCHENCO
Journal:  J Bacteriol       Date:  1957-12       Impact factor: 3.490

6.  Studies on antibacterial factors in mammalian tissues and fluids. I. A serum bactericidin for Bacillus subtilis.

Authors:  Q N MYRVIK; R S WEISER
Journal:  J Immunol       Date:  1955-01       Impact factor: 5.422

7.  Lack of bactericidal effect of mouse serum on a number of common microorganisms.

Authors:  S MARCUS; D W ESPLIN; D M DONALDSON
Journal:  Science       Date:  1954-06-18       Impact factor: 47.728

8.  Mutants of Escherichia coli requiring methionine or vitamin B12.

Authors:  B D DAVIS; E S MINGIOLI
Journal:  J Bacteriol       Date:  1950-07       Impact factor: 3.490

9.  The properdin system and immunity. V. The bactericidal activity of the properdin system.

Authors:  A C WARDLAW; L PILLEMER
Journal:  J Exp Med       Date:  1956-05-01       Impact factor: 14.307

10.  THE ACTIVATING EFFECT OF MAGNESIUM AND OTHER CATIONS ON THE HEMOLYTIC FUNCTION OF COMPLEMENT.

Authors:  M M Mayer; A G Osler; O G Bier; M Heidelberger
Journal:  J Exp Med       Date:  1946-11-30       Impact factor: 14.307

View more
  50 in total

1.  Release of 14C label and complement killing of Escherichia coli.

Authors:  B M Wilson; A A Glynn
Journal:  Immunology       Date:  1975-03       Impact factor: 7.397

2.  PH OPTIMA IN IMMUNE HEMOLYSIS: A COMPARISON BETWEEN GUINEA PIG AND HUMAN COMPLEMENT.

Authors:  S YACHNIN; J M RUTHENBERG
Journal:  J Clin Invest       Date:  1965-01       Impact factor: 14.808

3.  ENHANCEMENT BY LYSOZYME AND HYALURONIDASE OF THE PENETRATION BY TOXOPLASMA GONDII INTO CULTURED HOST CELLS.

Authors:  E LYCKE; E LUND
Journal:  Br J Exp Pathol       Date:  1965-04

4.  CHARACTERIZATION OF THE BACTERICIDAL ACTION OF PRECOLOSTRAL PIGLET AND CALF SERA AGAINST GRAM NEGATIVE ENTERIC BACTERIA IN ROUGH PHASE.

Authors:  D K TACHIBANA
Journal:  Folia Microbiol (Praha)       Date:  1965-05       Impact factor: 2.099

5.  The effect of ionic strength on the haemolytic activity of complement.

Authors:  A C WARDLAW; H G WALKER
Journal:  Immunology       Date:  1963-05       Impact factor: 7.397

6.  In vitro synthesis of immunoglobulins, secretory component, complement and lysozyme by human gastrointestinal tissues. I. Normal tissues.

Authors:  R F Lai A Fat; D B McClelland; R van Furth
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

7.  Sensitization of complement-resistant smooth gram-negative bacterial strains.

Authors:  B L Reynolds; H Pruul
Journal:  Infect Immun       Date:  1971-03       Impact factor: 3.441

8.  Release of endotoxic lipopolysaccharide by sensitive strains of Escherichia coli submitted to the bactericidal action of human serum.

Authors:  J Demonty; J De Graeve
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

9.  Serum sensitivity of a Pseudomonas aeruginosa mucoid strain.

Authors:  N L Schiller; M J Alazard; R S Borowski
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

10.  The bactericidal activity of sera of healthy neonates and of newborns with hyperbilirubinaemia to Escherichia coli.

Authors:  I Miler; J Vondrácek; L Hromádková
Journal:  Folia Microbiol (Praha)       Date:  1979       Impact factor: 2.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.